(Q54096102)

24 May 2018

title

High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. (English)

1 reference

24 May 2018

0 references

3

1 reference

24 May 2018

author name string

van Pampus MG

1

1 reference

24 May 2018

Dekker GA

2

1 reference

24 May 2018

Huijgens PC

4

1 reference

24 May 2018

Koopman MM

5

1 reference

24 May 2018

von Blomberg BM

6

1 reference

24 May 2018

Büller HR

7

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 May 1999

1 reference

24 May 2018

American Journal of Obstetrics and Gynecology

published in

1 reference

24 May 2018

volume

180

1 reference

24 May 2018

issue

5

1 reference

24 May 2018

page(s)

1146-1150

1 reference

24 May 2018

Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Pre-eclampsia: more than pregnancy-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Underlying disorders associated with severe early-onset preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Increased fetal loss in women with heritable thrombophilia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Preeclampsia is associated with a reduced response to activated protein C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

The factor V Leiden mutation may predispose women to severe preeclampsia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Mutation in blood coagulation factor V associated with resistance to activated protein C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Reduced response to activated protein C is associated with increased risk for cerebrovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970608-3

10.1016/S0002-9378(99)70608-3

7 January 2021

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018